Mon-Sun: 9.00 AM - 6.00 PM
+919696097866 /+912512400397

The 2nd Japan – India Medical Products Regulation Symposium to be held in Tokyo

The 2nd Japan – India Medical Products Regulation Symposium to be held in Tokyo

The 2nd Japan – India Medical Products Regulation Symposium to be held in Tokyo – April 10, 2017

The 2nd Japan – India Medical Products regulations symposium will be held in Tokyo on 24th April. In this symposium, following the first symposium held in New Delhi (India) in May last year, we will share the best practices in the regulation of pharmaceuticals and medical devices in both India and Japan and discuss the international regulatory harmonization and cooperation. Through these activities, Japan and India aim to improve the level of regulatory systems in both countries as well as to facilitate the regulatory compliance by industries. In this symposium following will be discussed.

  1. Development of the bilateral regulatory cooperation between Japan and India
  2. Latest trend of pharmaceutical and medical device regulation in Japan and India
  3. Quality standards and GMP system in India and Japan
  4. Clinical Trials in India and Japan
  5. Risk based inspection in India
  6. Industry’s response and preparation to the medical device regulation in India

The Directors of MHFW (Ministry of Health, Family and Welfare), CDSCO (Central Drugs Standard Control Organization),  MHLW (Ministry of Health, Labour and Welfare) and PMDA (Pharmaceutical and Medical Device Agency) will be present in the symposium.

Mr. Toshihiko Takeda, Director General (MHLW) will be delivering the opening remarks and  Dr. S. Eswara Reddy, who is Joints Drug Controller of CDSCO will be handling all the Medical devices regulation panels in Tokyo.


Subscribe to our Newsletter


Send replies to this news


The technical inputs, quality of work and translation output provided by M/s. InClinition, Dombivli, Mumbai, India were found satisfactory and meeting the latest standards. We recommend them for any kind of translation projects in future.

Dr. Ashish Mungantiwar
Dr. Ashish MungantiwarPresident-Medical Services, Mcleods Pharmaceuticals Ltd.

We found their suggestions and guidelines appropriate to our formulation range. InClinition Team has expert domain knowledge. They involved all our staff during conduction of audit and created positive approach towards audit. We strongly recommend their services and wish a continued support from them.

Mr. Nandkishor Deshpande
Mr. Nandkishor DeshpandeDirector, Debco Homeopathic Pharmaceuticals

On occasion of InClinition's 1st International Scientific Conference, we wish a grand success to conference.

Mr. Pranab Mukherjee
Mr. Pranab MukherjeePresident, Republic of India
Phone: +919696097866 /+912512400397
Corporate office: 91Springboard Lotus, Plot No.5, Road No.20, Marol MIDC, Andheri (East)-400069, Mumbai, India
Registered Office: S2/3, Shri Devdoot, Phule Road, Dombivli (West), Mumbai, India